Search:
CV Staiman

VICTORIA R. STAIMAN, M.D.

Chesapeake Urology Associates, P.A.

Pine Heights Medical Center at St. Agnes Hospital
1001 Pine Heights Avenue, Suite 100
Baltimore, MD 21229
410-644-0929 - Office
410-644-4338 - Fax

Chesapeake Urology Associates, P.A.

10700 Charter Drive, #310
Columbia, MD 21044
410-715-2090 - Office
410-715-1864 - Fax

Chesapeake Urology Associates, P.A.
8322 Bellona Avenue, Suite 202
Towson, MD 21204
410-825-6310 - Office
410-825-6320 - Fax

EDUCATION:

 

            5/1993                        New York Medical College

                                                Valhalla, New York

                                                Doctor of Medicine

 

            8/1989                        Rensselaer Polytechnic Institute

                                                Troy, New York

                                                M.S.

 

            5/1987                        Rensselaer Polytechnic Institute

                                                Troy, New York

                                                B.S.

 

RESIDENCY TRAINING:

 

            6/1993-6/1995           St. Luke's Roosevelt Hospital Center

                                                New York, New York

                                                Resident and Surgical Intern/Department of Surgery

 

            7/1995-6/1996           Columbia Presbyterian Medical Center

                                                New York, New York

                                                Urology Resident/Department of Urology

 

RESEARCH:

 

1987-1999                   A 58 KD protein related to virulence in Legionella pneumophila:Dr.

                                    Michael Hanna, Department of Biology, Rensselaer Polytchnic

                                    Institute, Troy, NY

 

7/1996-12/1996         Ligand-independent activation of the androgen receptor in benign

                                    hyperplasia prostate tissue explants with insulin-like growth

                                    factor-1 and human growth hormone as determined by prostate

                                    specific antigen secretion. Dr. William Rosner, Department of

                                    Endocrinology, St. Luke's/Roosevelt Hospital Center, New York,

                                    NY

 

CLINICAL STUDIES:

 

  • Open Study, Alza Corporation, Clinical Investigator, Urologic Surgery Associates, Towson, MD.

 

  • Pfizer

Principal Investigator                                                       July 2007- Present

A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Trial to Evaluate the Efficacy And Safety of a Fesoterodine Flexible Dose Regimen in Patients With Overactive Bladder

 

  • Celsion Corporation

Sub-Investigator                                                                May 2007-Present

"Post-Marketing Study Using Prolieve for the Treatment of Benign Prostate Hyperplasia (BPH)"

 

  • Pfizer

Sub-Investigator                                                                  November 2007-Present 

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fesoterodine as a "Add-On" Therapy in Men With Persistent Overactive Bladder Symptoms under Monotherapy of Alpha Blocker for Lower Urinary Tract Symptoms

 

  • Bioniche Therapeutics Limited

Sub-Investigator                                                                  May 2008-Present

Open-Label, Multi-Center Study of the Efficacy and Safety of MMC in the Treatment In Patients with Non-Muscle Invasion (Superficial) Bladder Cancer at High Risk of Progression and who are Refractory to BCG

 

 

ADDITIONAL PROFESSIONAL EXPERIENCE:

1987-1989                   Instructor: Introduction to Biology and Cell Biology, Department

                                    of Biology, Rensselaer Polytechnic Institute, Troy, NY

 

2000-2004                   Expert Reviewer, Urology, Infectious Disease Category

 

COMMITTEES:

 

  • Surgical Policy Committee, Union Memorial Hospital, Baltimore, MD, 2000-2002
  • Performance Improvement Committee, Howard County General Hospital, Howard County, MD, 2004-2006

 

 

PUBLICATIONS:

 

  • Staiman VR, O'Toole KC, Rubin MA, and Lowe FC. Giant malignant fibrous histiocytoma of the testis/spermatic cord: psychological and possible etiologic complications of unethical Nazi medical experimentation. Urology 48 (6): 939-943, 1996.
  • Staiman VR, and Hensle TW. Modified tabularized incised plate urethroplasty: surgical technique and clinical outcome. Current Surgical Techniques in Urology 10: 1-10, 1997.
  • Staiman VR, and Kaplan SA. Therapy for diabetes mellitus and related disorders, Bladder dysfunction. American Diabetes Association for Clinical Education Series, Third Edition, 1998.
  • Staiman VR, and LoweFC. Tamoxifen for flutamide/finasteride-induced gynecomastia. Urology 50: 929-933, 1997.
  • Staiman VR, and Lowe FC. Five Minute Urology Consult. Gynecomastia, 1999.
  • Knowles DR, Staiman VR, and Gupta M. Long-term results of the treatment of complete distal ureteral stenosis using a cutting balloon catheter device. Journal of Urology 166 (6): 2087-2090, 2001.

 

PRESENTATIONS:

  • The spectrum of prostate disease in HIV-infected patients: prostatic abscess, and emerging problem. Valentine Essay Contest, New York Academy of Medicine, New York, March 29, 1995.
  • Androgen receptor activation by insulin like growth factor-1 and growth hormone in benign hyperplasia tissue explants in the absence of androgens. Valentine Essay Contest, New York Academy of Medicine, New York, March 26, 1997.
  • The treatment of flutamide and finasteride induced painful gynecomastia with tamoxifen. American Urologic Association, Podium Presentation, New Orleans, LA, April 15, 1997
  • Techniques of endoscopic ureteroneocystostomy (video presentation).World Congress on Endourology and SWL, New York, NY, September 4, 1998.
  • Anterior trapezoidal bladder neck tube reconstruction produces excellent urinary continence following radical retropubic prostatectomy. American Urologic Association, Poster Presentation #1370. Dallas, TX, 1999.
  • Testicular Cancer. Men's Health Lecture Series, St. Joseph Medical Center, Baltimore, MD, 1999.
  • Diagnosis and treatment of hydronephrosis in the pediatric population. Pediatric Grand Rounds, Union Memorial Hospital, Baltimore, MD, 2001.

  

NOTEWORTHY HONORS AND AWARDS:

 

            2000                            Baltimore Magazine, "Top Doc"